Professor Anthony Joshua completed his medical oncology training at the Royal Prince Alfred hospital in Sydney, Australia and then completed a PhD in prostate cancer and a clinical fellowship at the Princess Margaret Cancer Centre in Toronto, Canada. He joined the Department of Medical Oncology as a staff oncologist in late 2008, specialising in prostate cancer with research interests in circulating tumour DNA, tumour heterogeneity, mechanisms of enzalutamide resistance and autophagy, where he has published close to 100 scientific articles. He returned to Australia, joining the Kinghorn Cancer Centre and the Garvan Institute of Medical Research in late 2015. He is currently a conjoint Professor with the University of New South Wales and the University of Notre Dame.